Inspiring Women’s Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System

Mindray (SZSE: 300760), a global leading developer and provider of medical devices and solutions, has introduced the Nuewa I9, its latest cart-based ultrasound system and tailored solution for Obstetrics and Gynecology (OB/GYN). Committed to inspiring women’s healthcare, Mindray’s Nuewa I9 elevates scanning capacity to new levels by combining innovative design and exceptional imaging quality with the latest technologies.

Inspiring Women’s Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System
Inspiring Women’s Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System (PRNewsfoto/Mindray)

“Nuewa I9 offers an unrivaled ultrasound scanning experience in its class. Each feature and innovation have been deliberately designed to address the daily challenges of OB/GYN clinicians. The result is a full-stack smart solution for extraordinarily efficient care, which covers the entire continuum from pre-pregnancy to obstetrics and post-partum,” said He Xujin, General Manager of Mindray Imaging System Division.

Nuewa I9 boasts a well-thought-out design for the ultimate convenience. Its foldable height and compact body allow the system to easily pass through doors for quick access across departments. Meanwhile, the breakthrough exam-specific iConsole control panel is optimized to adapt to different clinical scenarios, and its E-ink keys can be easily customized for the most frequently used functions.

The entire solution is powered by Mindray’s revolutionary ZST+ platform, which overcomes traditional trade-off limitations to deliver exceptional image quality for infinite imaging solutions with non-stop improvements. Nuewa I9 is also packed with automated tools to improve workflow and efficiency in women’s and neonatal care, such as Smart-VTrace, Smart Pelvic and Smart Hip.

One of the biggest innovations featured in Mindray’s Nuewa I9 is Smart Scene 3D, a scenario-oriented volume scan technique that enables the automatic identification of tissue characteristics and provides an organ-specific diagnosis. The technology supports the whole examination procedure starting with auto clinical scenario identification, then harnesses automation at every point from imaging optimization to plane acquisition, quantification, and the creation of an automated workflow. As a result, Nuewa I9 alleviates the workload of manual operation; reduces scanning time for individual patients; and delivers a truly easy, accurate and fast diagnosis.

Nuewa I9 also makes 3D/4D interactions extremely intuitive with reduced knob adjustments. Clinicians need only to click and choose their desired effect for different application scenarios, such as Routine, iLive, Bone, Tissue, and Follicle. Preset imaging settings have been integrated in the system for optimal volume imaging effects, and support ease of use in every possible clinical scenario for OB/GYN.

SOURCE Mindray

Inspiring Women’s Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System

It’s part of the company’s mission to equip its Medicare Advantage members with easy-to-use tools and resources to manage their health and live healthier lives

CarePlus Health Plans, Inc., Florida’s largest* Medicare Advantage plan rated 5 out of 5 stars for 2021, and Sharecare, the digital health company that helps people manage all their health in one place, are collaborating to make it easier for CarePlus Medicare Advantage members across Florida to take an active role in improving their health.

“We’re thrilled to team with Sharecare to inspire our members to live their healthiest lives possible, no matter where they are on their health journey,” said Bruno Piquin, CarePlus Health Plans President. “Access to Sharecare will help our members more easily manage their health and well-being in one place, track their progress, and get rewarded along the way.”

Sharecare’s digital health experience, which includes an easy-to-use mobile app, enables CarePlus members to go from assessment to action. The digital experience starts with the RealAge® test, Sharecare’s clinically validated health risk assessment that shows members the true age of their bodies. It then provides personalized action plans to guide and educate members on health factors that may impact longevity and real-time tracking of daily health goals.

All CarePlus Medicare Advantage plans now offer access to Sharecare. CarePlus members can also use Sharecare to track and redeem CarePlus Rewards for completing certain healthy activities. The CarePlus Rewards program is offered to members free of charge.

“There is an opportunity to leverage the power of personal technology to help Medicare beneficiaries gain better access to care and increase utilization of the critical resources available to them,” said Pam Shipley, Chief Operating Officer at Sharecare. “At Sharecare, we are fiercely committed to bringing much needed scalable innovation to health care, and we are excited to partner with CarePlus by empowering their members to take control of their personal health and well-being, right in the palm of their hand.”

Inspiring Women’s Healthcare: Mindray Unveils Nuewa I9, a New OB/GYN Diagnostic Ultrasound System

Ultraviolet (UV) technology developed by the New York-based firm PurpleSun Inc. eliminates more than 96 percent of pathogens in operating rooms (ORs) and on medical equipment, compared to 38 percent using manual cleaning methods that rely on chemicals to disinfect surfaces, according to a study published this month in the American Journal of Infection Control (AJIC).

Health care is in constant battle to maintain a clean and pathogen-free patient care environment. To improve quality and reduce risk, hospitals use established protocols for cleaning and disinfecting ORs and medical equipment with chemical wipes after each case. Medical equipment ranges from surgical robots, microscopes and scanners to patient beds and stretchers.

“The challenge from an infection control standpoint is that microbes and bacteria are invisible to the human eye, and there is potential for errors in the manual cleaning and disinfection process, whether it’s attributable to inadequate staffing, poor training, lack of adherence to manufacturers’ instructions or other human error,” said Donna Armellino, RN, DNP, vice president of infection prevention at Northwell Health, who was the lead author on this study. Among other factors, for instance, the disinfectants may have the wrong dilution, be incompatible with the materials used to clean, may not be in contact with the equipment long enough, or the chemicals may be improperly stored, reducing their pathogen-destroying effectiveness, she said.

To assess the current standard of cleaning and disinfection in ORs, Northwell clinicians teamed with PurpleSun, which developed a focused multivector, ultraviolet (FMUV) device that is used to supplement manual cleaning. FMUV takes 90 seconds to fully disinfect surfaces. They evaluated the current standard of cleaning in the OR with and without the use of FMUV.

As part of the study, researchers assessed pathogen presence by performing tests on equipment that was reported out in colony-forming units (CFUs). CFUs represent pathogens that could potentially increase the risk of a hospital-acquired infection. The testing was done before manual cleaning, after manual-chemical cleaning and disinfection, and after the automated FMUV light technology using a five-point assessment technique. The aggregate CFUs following manual-chemical disinfection compared to pre-cleaning showed a 38 percent effectiveness at killing pathogens, whereas the process using FMUV was 96.5 percent effective at reducing the level of reported CFUs.

“The study supports the fact that operating rooms are clean, but not as clean as we’d like following manual chemical cleaning and disinfection. FMUV has the potential for changing the cleanliness of operating rooms,” said Dr. Armellino. Her co-authors on the study were Kristine Goldstein, RN, and Linti Thomas, RN, of Northern Westchester Hospital; and Thomas J. Walsh, MD, and Vidmantas Petraitis, MD, both of Weill Cornell Medicine of Cornell University.

The American Journal of Infection Controlis the clinical journal of the Association of Professionals in Infection Control.

Northwell Health is an investor in PurpleSun’s technology, and is currently using the technology in ORs at Northern Westchester Hospital in Mount Kisco and Staten Island University Hospital, as well as the neonatal intensive care unit at Cohen Children’s Medical Center in New Hyde Park.

About Northwell Health

Northwell Health is New York State’s largest health care provider and private employer, with 23 hospitals, about 750 outpatient facilities and more than 13,600 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 70,000 employees – 16,000-plus nurses and 4,000 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We’re making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We’re training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Graduate Nursing and Physician Assistant Studies. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Twitter, Instagram and LinkedIn.

Scroll to top